251 related articles for article (PubMed ID: 8774614)
1. Stromal abnormalities in neoplastic bone marrow diseases.
Dührsen U; Hossfeld DK
Ann Hematol; 1996 Aug; 73(2):53-70. PubMed ID: 8774614
[TBL] [Abstract][Full Text] [Related]
2. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages.
Bhatia R; McGlave PB; Dewald GW; Blazar BR; Verfaillie CM
Blood; 1995 Jun; 85(12):3636-45. PubMed ID: 7780147
[TBL] [Abstract][Full Text] [Related]
3. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
4. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
[TBL] [Abstract][Full Text] [Related]
5. Perturbation in the ability of bone marrow stroma from patients with acute myeloid leukemia but not chronic myeloid leukemia to support normal early hematopoietic progenitor cells.
Sparrow RL; O'Flaherty E; Blanksby TM; Szer J; Van Der Weyden MB
Leuk Res; 1997 Jan; 21(1):29-36. PubMed ID: 9029183
[TBL] [Abstract][Full Text] [Related]
6. Characterization of bone marrow stromal abnormalities in a patient with constitutional trisomy 8 mosaicism and myelodysplastic syndrome.
Narendran A; Hawkins LM; Ganjavi H; Vanek W; Gee MF; Barlow JW; Johnson G; Malkin D; Freedman MH
Pediatr Hematol Oncol; 2004; 21(3):209-21. PubMed ID: 15202160
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow niche in the myelodysplastic syndromes.
Cogle CR; Saki N; Khodadi E; Li J; Shahjahani M; Azizidoost S
Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
[TBL] [Abstract][Full Text] [Related]
8. [Pathomechanism and clinical impact of myelofibrosis in neoplastic diseases of the bone marrow].
Bedekovics J; Méhes G
Orv Hetil; 2014 Mar; 155(10):367-75. PubMed ID: 24583557
[TBL] [Abstract][Full Text] [Related]
9. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1991; 12():327-46. PubMed ID: 1931449
[No Abstract] [Full Text] [Related]
10. Harlequin cell: Ubiquitous or pathognomic?
Jain G; Kumar C; Chopra A
Int J Lab Hematol; 2020 Apr; 42(2):e42-e44. PubMed ID: 31424608
[No Abstract] [Full Text] [Related]
11. Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.
Winfield DA; Polacarz SV
J Clin Pathol; 1992 Oct; 45(10):855-9. PubMed ID: 1430254
[No Abstract] [Full Text] [Related]
12. Composition and function of the hemopoietic microenvironment in human myeloid leukemia.
Mayani H
Leukemia; 1996 Jun; 10(6):1041-7. PubMed ID: 8667639
[TBL] [Abstract][Full Text] [Related]
13. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1990; 11():321-42. PubMed ID: 2223398
[No Abstract] [Full Text] [Related]
14. [The role of stromal and hematopoietic tissue interaction in pathology of hematopoiesis].
Morozova VT
Klin Lab Diagn; 2003 Aug; (8):33-6. PubMed ID: 14524126
[No Abstract] [Full Text] [Related]
15. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
16. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1992; 13():327-48. PubMed ID: 1389914
[No Abstract] [Full Text] [Related]
17. [Chronic granulocytic leukemia (Ph+): among yesterday's myeloproliferative syndromes, today's chronic myeloid leukemias, and tomorrow's mature-element monocellular myelopathies].
Sánchez Fayos J; Prieto E; Chica Gullón E
Sangre (Barc); 1998 Apr; 43(2):121-6. PubMed ID: 9656773
[No Abstract] [Full Text] [Related]
18. Severe hematopoietic alterations in vitro, in bone marrow transplant recipients who develop graft-versus-host disease.
Martínez-Jaramillo G; Gómez-Morales E; Sánchez-Valle E; Mayani H
J Hematother Stem Cell Res; 2001 Jun; 10(3):347-54. PubMed ID: 11454310
[TBL] [Abstract][Full Text] [Related]
19. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
Novitzky N; Mohamed R
Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of bone marrow microenvironment could change how myelodysplastic syndromes are diagnosed and treated.
Aanei CM; Catafal LC
Cytometry A; 2018 Jul; 93(9):916-928. PubMed ID: 30211968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]